MENU
ELV
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ELV stock forecast, quote, news & analysis

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025... Show more

ELV
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for ELV with price predictions
Aug 14, 2026

ELV in upward trend: price expected to rise as it breaks its lower Bollinger Band on July 16, 2026

ELV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 37 cases where ELV's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 05, 2026. You may want to consider a long position or call options on ELV as a result. In of 99 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ELV just turned positive on August 06, 2026. Looking at past instances where ELV's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

ELV moved above its 50-day moving average on August 12, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ELV advanced for three days, in of 318 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 10-day moving average for ELV crossed bearishly below the 50-day moving average on July 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.934) is normal, around the industry mean (3.842). P/E Ratio (17.705) is within average values for comparable stocks, (158.158). Projected Growth (PEG Ratio) (1.417) is also within normal values, averaging (1.253). Dividend Yield (0.017) settles around the average of (0.020) among similar stocks. P/S Ratio (0.440) is also within normal values, averaging (0.593).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ELV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

ELV paid dividends on June 25, 2026

Elevance Health ELV Stock Dividends
А dividend of $1.72 per share was paid with a record date of June 25, 2026, and an ex-dividend date of June 10, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Unitedhealth Group (NYSE:UNH), CVS HEALTH Corp (NYSE:CVS), Elevance Health (NYSE:ELV), Cigna Group (The) (NYSE:CI), Humana (NYSE:HUM), Centene Corp (NYSE:CNC).

Industry description

Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.

Market Cap

The average market capitalization across the Managed Health Care Industry is 68.63B. The market cap for tickers in the group ranges from 1.01M to 360.59B. UNH holds the highest valuation in this group at 360.59B. The lowest valued company is IHGP at 1.01M.

High and low price notable news

The average weekly price growth across all stocks in the Managed Health Care Industry was 2%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 53%. OSCR experienced the highest price growth at 17%, while PGNY experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Managed Health Care Industry was -35%. For the same stocks of the Industry, the average monthly volume growth was -18% and the average quarterly volume growth was -34%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 46
Price Growth Rating: 49
SMR Rating: 79
Profit Risk Rating: 88
Seasonality Score: 0 (-100 ... +100)
View a ticker or compare two or three
ELV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a provider of life, hospital and medical insurance plans

Industry ManagedHealthCare

Profile
Details
Industry
Managed Health Care
Address
220 Virginia Avenue
Phone
+1 833 401-1577
Employees
104900
Web
https://www.elevancehealth.com
ELV in upward trend: price expected to rise as it breaks its lower Bollinger Band on July 16, 2026